News & Analysis as of

US China Trade War–Developments In Trade, Customs, Patents, Antitrust And Securities

There have been some major developments in the trade, solar cells, Customs, 337/patents, antitrust and securities areas. On September 26th there were reports that the United States and China have been negotiating for the past...more

What Chinese Businesses Need to Know About Establishing an R&D Center in the United States

There is increasing interest from Chinese businesses in establishing an R&D center in the Silicon Valley and other technology centers in the United States. For example, the world’s largest mobile phone operator, China Mobile,...more

Legal Overview of China’s Regulation on Payment Service by Non-Financial Institutions

At ACI’s 2nd Advanced Forum on International & Cross-Border Payments in San Francisco, DWT partner Vincent Wang gave a presentation entitled “Legal Overview of China’s Regulation on Payment Service by Non-Financial...more

Formation and Structural Considerations for U.S. Operations of Chinese Insurance Companies

Although China has a national insurance regulator – the China Insurance Regulatory Commission (CIRC) – Chinese insurers must be licensed in each province or independent municipality in which they wish to operate. The current...more

Formation and Structural Considerations for U.S. Operations of Chinese Insurance Companies

Although China has a national insurance regulator – the China Insurance Regulatory Commission (CIRC) – Chinese insurers must be licensed in each province or independent municipality in which they wish to operate. The current...more

Asian Regulatory RoundUp - March 2013

In This Issue: - Greater China - Hong Kong - Taiwan - Singapore - India...more

China SFDA Creates New Regulatory Pathways for Transfer of Drug Licenses

To accelerate GMP compliance by domestic pharmaceutical companies, the Chinese State Food and Drug Administration (“SFDA”) published a notice on February 22, 2013 (the “Notice”) clarifying the regulatory pathways for...more

Skadden's 2013 Insights

We are pleased to provide a collection of commentaries on the critical legal issues facing our clients in 2013. There is hope that global economic and market conditions will continue to improve despite ongoing...more

China Life Sciences - January 2013

In This Issue: Investor Q&A; Key Regulatory Issues for Strategic Life Sciences Partnerships in China; Compulsory Patent Licensing in China; and New Developments on the “Patentable Subject Matter” Requirement of U.S....more

Single Purpose Commercial Prepaid Cards and Their Implementing Practices in Shanghai

In September 2012, the Ministry of Commerce (“MOFCOM”) issued the Administrative Measures on Single Purpose Commercial Prepaid Cards (Tentative) (“Single Purpose Cards Measures”), which took effect on Nov. 1, 2012, and...more

China Life Sciences and Health Industry Client Briefing – November 2012 (December 13, 2012)

In This Issue: Priorities, Practical Tips and Lessons Learned from Reed Smith’s China Device Regulatory Briefing on December 4, 2012; Programs of Designated Drug Production to be Initiated: Five to 10 Pilot Varieties...more

11 Results
|
View per page
Page: of 1